EpimedX, LLC Email Format

Biotechnology ResearchOklahoma, United States2-10 Employees

EpimedX, LLC is a Oklahoma-based biotechnology company founded in 2011, focused on developing Gene Regulation Therapy© as a potential treatment approach for sickle cell disease, beta-thalassemia, and malaria. With a small team, the company operates within the biotechnology research sector, aiming to offer a therapy that could provide a safe, cost-effective, and long-lasting solution for these conditions. Its work targets patients affected by genetic blood disorders and malaria, addressing the need for durable and side-effect-conscious treatment options. Located in Oklahoma City, EpimedX situates itself within a regional science and research community, pursuing what is described as a promising therapeutic modality in gene regulation. A recent development note indicates ongoing activity in its research focus, reflecting continued progress in its core mission.

Sign up for free to view info

Company overview Employee directory